Detalles de la búsqueda
1.
Evaluation of the diagnostic performance of the EFSUMB CEUS Pancreatic Applications guidelines (2017 version): a retrospective single-center analysis of 455 solid pancreatic masses.
Eur Radiol;
32(12): 8485-8496, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35699767
2.
[Advances in Treatment of Human Epidermal Growth Factor Receptor 2-Positve Gastric Cancer].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao;
44(5): 899-905, 2022 Oct.
Artículo
en Zh
| MEDLINE | ID: mdl-36325789
3.
[Predictive Biomarkers of Immune-related Adverse Events Induced by Checkpoint Inhibitors in Malignancies].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao;
42(6): 825-830, 2020 Dec 30.
Artículo
en Zh
| MEDLINE | ID: mdl-33423733
4.
[Application of Single-cell RNA Sequencing in Research on Tumor Immune Microenvironment].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao;
42(1): 117-123, 2020 Feb 28.
Artículo
en Zh
| MEDLINE | ID: mdl-32131950
5.
Pathological evaluation of neoadjuvant chemotherapy in advanced gastric cancer.
World J Surg Oncol;
17(1): 3, 2019 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30606195
6.
[Expression of α-smooth Muscle Actin in Advanced Colorectal Cancer Tissue and Its Significance in Chemotherapy Response Prediction and Prognosis].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao;
41(1): 63-67, 2019 Feb 28.
Artículo
en Zh
| MEDLINE | ID: mdl-30837044
7.
[Gut Microbiome Differences between Gastrointestinal Cancer Patients and Healthy People].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao;
41(5): 636-645, 2019 Oct 30.
Artículo
en Zh
| MEDLINE | ID: mdl-31699194
8.
[Clinical Analysis of 25 Cases of Malignant Peritoneal Mesothelioma].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao;
40(2): 211-218, 2018 Apr 28.
Artículo
en Zh
| MEDLINE | ID: mdl-29724311
9.
[Efficacy and Prognostic Factors of Cetuximab Therapy in Treating KRAS or All RAS Wild-type Metastatic Colorectal Cancer].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao;
40(5): 660-666, 2018 Oct 30.
Artículo
en Zh
| MEDLINE | ID: mdl-30404699
10.
Efficacy of Gemcitabine and S-1 for Patients with Advanced Pancreatic Cancer.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao;
39(4): 562-567, 2017 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-28877836
11.
Single Nucleotide Polymorphisms of Paclitaxel-induced Peripheral Sensory Neuropathy in Chinese Han Population.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao;
39(5): 593-601, 2017 10 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-29125099
12.
KLF17 Expression in Colorectal Carcinoma and Its Clinical Significance.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao;
38(1): 69-72, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26956859
13.
Efficiency of Sunitinib in Chinese Patients with Advanced Progressive Pancreatic Neuroendocrine Tumor.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao;
38(3): 300-4, 2016 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27469915
14.
Cancer biomarkers and personalized cancer medicine.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao;
37(1): 113-7, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25676280
15.
[Three-dimensional Pseudo-continuous Arterial Spin Label Non-contrast Enhanced Perfusion Imaging of Head and Neck Tumors with High-field MR System].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao;
37(5): 567-74, 2015 Oct.
Artículo
en Zh
| MEDLINE | ID: mdl-26564509
16.
Chromogranin A is a reliable serum diagnostic biomarker for pancreatic neuroendocrine tumors but not for insulinomas.
BMC Endocr Disord;
14: 64, 2014 Aug 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-25099181
17.
[Chemotherapy risk assessment for elderly patients].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao;
36(5): 551-5, 2014 Oct.
Artículo
en Zh
| MEDLINE | ID: mdl-25360657
18.
[Application of micro-computed tomography (µCT)in quantifying xylem vessels of broadleaved trees]. / 计ç®æºæ¾å¾®æå±æ«æææ¯(µCT)å¨éåéå¶æ ç§å¯¼ç®¡ä¸çåºç¨.
Ying Yong Sheng Tai Xue Bao;
35(5): 1214-1222, 2024 May.
Artículo
en Zh
| MEDLINE | ID: mdl-38886419
19.
Synthesis, molecular docking studies of formononetin derivatives as potent Bax agonists for anticancer activity.
Nat Prod Res;
: 1-15, 2023 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37921074
20.
Pancreatic ductal adenocarcinoma with synchronous and metachronous hepatic metastasis predicted by contrast-enhanced ultrasound.
Quant Imaging Med Surg;
13(6): 3902-3914, 2023 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37284072